Accelerate Drug Discovery with Scalable Bioinformatics
From target discovery to translational research and clinical data analysis, Seqera provides the computational backbone for drug development. Built for bioinformatics. Trusted by life science innovators.
Request a DemoUnlock Scientific Breakthroughs in Drug Discovery
The journey from molecule to medicine is complex, iterative, and data-intensive. Whether you’re identifying novel targets, modeling protein structures, analyzing -omics data, or scaling up AI-driven discovery, the right infrastructure is key. Seqera empowers R&D teams with a unified platform to orchestrate, scale, and accelerate drug discovery workflows, from bench to bedside.
Target gene expression
CRISPR screening analysis
Variant calling analysis
Protein-drug interaction mapping
Single-cell drug response
Chromatin accessibility profiling
Quantitative proteomics analysis
Immunopeptidome target identification
Why Seqera for Drug Discovery?
In the era of big data, drug discovery demands infrastructure that can keep pace. Seqera powers everything from multi-omics analysis to protein structure prediction and pharmacogenomics. With reproducibility by design, flexible deployment, and deep support for AI and bioinformatics, Seqera gives R&D teams the agility and confidence to accelerate innovation.
Scalable R&D Workflows
Analyze massive experimental datasets without bottlenecks. Seamlessly scale across compute environments to match your drug discovery processes.
Seamless Analysis, Anywhere
Execute complex pipelines across cloud, on-prem, or hybrid environments. Seqera brings the compute to your data, integrating seamlessly with your infrastructure, without disruption.
Collaborate Across Functions
Centralize workflows and enable real-time collaboration across research, translational science, and clinical teams. Seqera breaks down silos across data and teams.
Reproducibility at Every Stage
Leverage version-controlled, containerized workflows using Nextflow and nf-core to ensure traceable, standardized results throughout discovery and development.
Expert Support
Partner with the creators of Nextflow and expert bioinformaticians who understand your technical challenges and goals. From pipeline optimization to scaling infrastructure, we help you advance drug discovery with confidence.
Security Built for Biopharma
Operate with confidence in regulated environments. Seqera supports enterprise-grade data governance, audit trails, and compliance for pharmaceutical R&D and beyond.
How Seqera powers every stage of drug discovery
Seqera unifies data, code, compute, and environments into a single, scalable platform, giving R&D teams across pharma and biotech the tools to streamline complex analyses and collaborate without friction. From target discovery to biomarker validation and clinical data analysis, Seqera accelerates drug pipelines by reducing infrastructure overhead and enabling reproducible, collaborative workflows—helping teams bring therapies to market faster with confidence.
Launch Scalable Analysis in One Click
Get started instantly with trusted, community-curated Nextflow pipelines from the nf-core community, or bring your own.
Discover real-world applications of Seqera
Explore applications of Nextflow and Seqera in drug discovery with these useful resources.
Trusted by 13 of 20 Top Pharma Companies
Leading biotech and pharmaceutical companies depend on Seqera to unify their data, teams, and tools across the discovery pipeline. From emerging therapeutics to scaled-up clinical programs, Seqera supports the most ambitious R&D efforts with infrastructure built to meet the demands of modern drug development.
Biopharma R&D
"Seqera provided an intuitive environment supporting early-stage research and clinical trials."
Strategic Partners
"Seqera’s market-leading solutions are becoming essential parts of the biotech architecture"
Translational Research
"We used AI and Nextflow to gain insights from brain scans to help select treatments. "
Data Processing
"We achieved 9-fold faster data processing and enhanced clinical trial efficiency with Seqera"
